UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

Journal of allergy and clinical immunology, 2009-10, Vol.124 (4), p.801-808

2009

Link zum Volltext

Verfügbarkeit prüfen

Co-Occurrence of C1 Esterase Inhibitor Deficiency and Autoimmune Disease: A Systematic Literature Review

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB43-AB43

2019

Link zum Volltext

Verfügbarkeit prüfen

Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

Journal of allergy and clinical immunology, 2018-06, Vol.141 (6), p.2037-2047.e10

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Attacks of Hereditary Angioedema (HAE) with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) by Anatomical Location: Results From the Phase III COMPACT Study (NCT01912456)

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB45-AB45

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Icatibant is Consistent by Attack Frequency and Baseline Severity in the Treatment of Type I and II Hereditary Angioedema (HAE) Attacks

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB218-AB218

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Prodromal Symptoms Concurrent with Hereditary Angioedema Therapy

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S100-S100

2009

Link zum Volltext

Verfügbarkeit prüfen

Patient Driven Automated Data Collection System Demonstrates Effectiveness of C1INH Rescue Therapy

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S105-S105

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB101-AB101

2011

Link zum Volltext

Verfügbarkeit prüfen

C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.S99-S99

2009

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB164-AB164

2010

Link zum Volltext

Verfügbarkeit prüfen

C1 Esterase Inhibitor: Retrospective Validation of a Commonly Used Endpoint in Hereditary Angioedema Studies, Time to Onset of Relief, in a Global, Multicenter, Randomized, Placebo-Controlled Study (I.M.P.A.C.T.1)

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB165-AB165

2010

Link zum Volltext

Verfügbarkeit prüfen

C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2)

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB166-AB166

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

Journal of allergy and clinical immunology, 2008-03, Vol.121 (3), p.795-795

2008

Link zum Volltext

Verfügbarkeit prüfen

C1 esterase inhibitor (C1-INH) - Standard of Care for the Treatment of Acute Attacks in Hereditary Angioedema (HAE): Initial Results of an Ongoing, Prospective, Open Label Study in North America (I.M.P.A.C.T.2)

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S98-S99

2008

Link zum Volltext

Verfügbarkeit prüfen

Addendum: Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

Journal of allergy and clinical immunology, 2008-03, Vol.121 (3), p.795-795

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

PublikationsformTagungsberichte

Zeitschrift / SerieJournal Of Allergy And Clinical Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(15)
Free E-Journal (出版社公開部分のみ）
(15)
Journals@Ovid Full Text
(15)
IngentaConnect Journals
(15)
Elsevier ScienceDirect Journals Complete
(15)
Single Journals
(15)
IngentaConnect Journals
(11)
MEDLINE
(2)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

Co-Occurrence of C1 Esterase Inhibitor Deficiency and Autoimmune Disease: A Systematic Literature Review

Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

Prevention of Attacks of Hereditary Angioedema (HAE) with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) by Anatomical Location: Results From the Phase III COMPACT Study (NCT01912456)

Efficacy of Icatibant is Consistent by Attack Frequency and Baseline Severity in the Treatment of Type I and II Hereditary Angioedema (HAE) Attacks

Evaluation of Prodromal Symptoms Concurrent with Hereditary Angioedema Therapy

Patient Driven Automated Data Collection System Demonstrates Effectiveness of C1INH Rescue Therapy

Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients

C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)

C1 Esterase Inhibitor: Retrospective Validation of a Commonly Used Endpoint in Hereditary Angioedema Studies, Time to Onset of Relief, in a Global, Multicenter, Randomized, Placebo-Controlled Study (I.M.P.A.C.T.1)

C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2)

Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

C1 esterase inhibitor (C1-INH) - Standard of Care for the Treatment of Acute Attacks in Hereditary Angioedema (HAE): Initial Results of an Ongoing, Prospective, Open Label Study in North America (I.M.P.A.C.T.2)

Addendum: Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

Aktive Filter

Suchergebnisse filtern